Meet Freya
October 2024
The Special Access Scheme (SAS) and Authorised Prescriber (AP) Online System offer health practitioners a streamlined method to apply for and notify unapproved therapeutic goods, including medicinal cannabis. The system facilitates a more efficient process for obtaining approval for unapproved medicines, allowing practitioners to access therapeutic goods that are not otherwise available in the market.
Key Features of the System:
Account Management:
Practitioners can create and manage their accounts within the system, allowing for easy submission and tracking of applications.
Site Affiliations:
Health practitioners can affiliate their account with specific sites or institutions, ensuring the proper routing of applications.
Validation and Search Tools:
Users can perform validation searches to confirm the availability and eligibility of therapeutic goods for use in applications.
Dashboards and Application Submission:
The system provides a comprehensive dashboard for managing applications, tracking progress, and submitting requests for unapproved therapeutic goods.
Health practitioners can submit details about the prescriber, product, and patient in their applications, specifying:
Therapeutic good (medicinal product).
Active ingredients, dosage, and indication for the treatment.
Medicinal Cannabis:
For medicinal cannabis, practitioners must collaborate with the relevant State or Territory Health Departments to ensure compliance with local regulations.
Tracking and Review:
Users can track the status of their applications in real-time, allowing them to stay informed about the progress of their requests.
Previous submissions can be reviewed, and copies of applications can be downloaded for record-keeping or further action.
The SAS and AP system simplifies the process of accessing unapproved therapeutic goods, ensuring that health practitioners can provide patients with necessary treatments while maintaining regulatory compliance.
Region: Australia
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert
